Gaillard JL - Search Results

1

Mycobacterium bolletii Lung Disease in Cystic Fibrosis.

Rollet-Cohen V, Roux AL, Le Bourgeois M, Sapriel G, El Bahri M, Jais JP, Heym B, Mougari F, Raskine L, Véziris N, Gaillard JL, Sermet-Gaudelus I. Rollet-Cohen V, et al. Among authors: gaillard jl. Chest. 2019 Aug;156(2):247-254. doi: 10.1016/j.chest.2019.03.019. Epub 2019 Mar 29. Chest. 2019. PMID: 30935892

2

Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis.

Gaillard JL, Cahen P, Delacourt C, Silly C, Le Bourgeois M, Coustère C, de Blic J, Lenoir G, Scheinmann P. Gaillard JL, et al. Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):291-6. doi: 10.1007/BF02116521. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7649191 Clinical Trial.

3

Value of ELISA using antigen 60 for the diagnosis of tuberculosis in children.

Delacourt C, Gobin J, Gaillard JL, de Blic J, Veron M, Scheinmann P. Delacourt C, et al. Among authors: gaillard jl. Chest. 1993 Aug;104(2):393-8. doi: 10.1378/chest.104.2.393. Chest. 1993. PMID: 8339625

4

Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.

Cahen P, Le Bourgeois M, Delacourt C, Coustère C, Nicaise P, de Blic J, Véron M, Scheinmann P, Gaillard JL. Cahen P, et al. Among authors: gaillard jl. Pediatrics. 1993 Feb;91(2):451-5. Pediatrics. 1993. PMID: 8424026

5

Rapid improvement of intracranial tuberculomas after addition of ofloxacin to first-line antituberculosis treatment.

Sermet-Gaudelus I, Stambouli F, Abadie V, Goutières F, Lenoir G, Gendrel D, Gaillard JL. Sermet-Gaudelus I, et al. Among authors: gaillard jl. Eur J Clin Microbiol Infect Dis. 1999 Oct;18(10):726-8. doi: 10.1007/s100960050386. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10584900

6

[Antibiotic therapy in cystic fibrosis. I. Pharmacologic specifics of antibiotics].

Sermet-Gaudelus I, Hulin A, Ferroni A, Silly C, Gaillard JL, Berche P, Lenoir G. Sermet-Gaudelus I, et al. Among authors: gaillard jl. Arch Pediatr. 2000 May;7(5):519-28. doi: 10.1016/s0929-693x(00)89009-0. Arch Pediatr. 2000. PMID: 10855392 French.

7

[Antibiotic therapy in cystic fibrosis. II Antibiotic strategy].

Sermet-Gaudelus I, Ferroni A, Gaillard JL, Silly C, Chretiennot C, Lenoir G, Berche P. Sermet-Gaudelus I, et al. Among authors: gaillard jl. Arch Pediatr. 2000 Jun;7(6):645-56. doi: 10.1016/s0929-693x(00)80134-7. Arch Pediatr. 2000. PMID: 10911533 Review. French.

8

Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Ferroni A, Sermet-Gaudelus I, Abachin E, Quesne G, Lenoir G, Berche P, Gaillard JL. Ferroni A, et al. Among authors: gaillard jl. J Clin Microbiol. 2002 Oct;40(10):3793-7. doi: 10.1128/JCM.40.10.3793-3797.2002. J Clin Microbiol. 2002. PMID: 12354883 Free PMC article.

9

[Phenotypic and genotypic characteristics of non fermenting atypical strains recovered from cystic fibrosis patients].

Ferroni A, Sermet-Gaudelus I, Abachin E, Quesnes G, Lenoir G, Berche P, Gaillard JL. Ferroni A, et al. Among authors: gaillard jl. Pathol Biol (Paris). 2003 Sep;51(7):405-11. doi: 10.1016/s0369-8114(03)00021-x. Pathol Biol (Paris). 2003. PMID: 12948761 French.

10

Mycobacterium abscessus and children with cystic fibrosis.

Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, Offredo C, Guillemot D, Halley S, Akoua-Koffi C, Vincent V, Sivadon-Tardy V, Ferroni A, Berche P, Scheinmann P, Lenoir G, Gaillard JL. Sermet-Gaudelus I, et al. Among authors: gaillard jl. Emerg Infect Dis. 2003 Dec;9(12):1587-91. doi: 10.3201/eid0912.020774. Emerg Infect Dis. 2003. PMID: 14720400 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

290 results

Search Page